Poland· PL-100416157
Dengvaxia
A dengue-virus-impfstoffe product containing czterowalentna szczepionka przeciw gorączce denga (żywa, atenuowana), registered in Poland by Sanofi Pasteur. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dengue-virus-impfstoffe is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BX04 (dengue-virus-impfstoffe), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Dengue-virus-impfstoffe · ATC J07BX04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Czterowalentna szczepionka przeciw gorączce denga (żywa, atenuowana)
- Manufacturer
- Sanofi Pasteur
- Country
- Poland (PL)
- ATC code
- J07BX04
- ATC class
- Dengue-Virus-Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909991393892
- gtin05909991393908
- gtin05909991393915
- gtin05909991393922
- gtin05909991393939
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX04
Dengue-virus-impfstoffe, as other registers publish it.
- DenmarkDengvaxiaSanofi Winthrop Industrie
- FinlandDengvaxiaSanofi Winthrop Industrie
- FinlandDengvaxiaSanofi Winthrop Industrie
- BelgiumDengvaxiaSanofi Winthrop Industrie
- BelgiumDengvaxiaSanofi Winthrop Industrie
- PolandQdengaTakeda Pharmaceuticals International AG Ireland Branch
- FinlandQdengaTakeda Pharmaceuticals International AG Ireland Branch
- BelgiumQdengaTakeda Pharmaceuticals International AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8c6b088e-6c60-43eb-bc80-46f49242adb3 GET /v1/drugs/8c6b088e-6c60-43eb-bc80-46f49242adb3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań w ampułko-strzykawce",
"source": "urpl",
"strength": "-",
"packaging": "05909991393892 ¦ Rp ¦ EU/1/18/1338/003 ¦ 131120\n1 fiol. 1 dawka proszku ¦ 1 amp.-strzyk. 0,5 ml rozp.\n05909991393908 ¦ Rp ¦ EU/1/18/1338/001 ¦ 131121\n1 fiol. 1 dawka proszku ¦ 1 amp.-strzyk. 0,5 ml rozp. ¦ 2 igły \n05909991393915 ¦ Rp ¦ EU/1/18/1338/004 ¦ 131122\n10 fiol. 1 dawka ¦ 10 amp.-strzyk. 0,5 ml\n05909991393922 ¦ Rp ¦ EU/1/18/1338/002 ¦ 131123\n10 fiol. 1 dawka proszku ¦ 20 igieł ¦ 10 amp.-strzyk. 0,5 ml rozp.\n05909991393939 ¦ Rp ¦ EU/1/18/1338/005 ¦ 131124\n5 fiol. 5 dawek proszku ¦ 5 fiol. 2,5 ml rozp.",
"substance": "Chimeryczny wirus żółtej gorączkii gorączki denga, serotyp 1 (żywy, atenuowany) 4,5 – 6,0 log10 CCID50/dawkę + Chimeryczny wirus żółtej gorączkii gorączki denga, serotyp 2 (żywy, atenuowany) 4,5 – 6,0 log10 CCID50/dawkę + Chimeryczny wirus żółtej gorączkii gorączki denga, serotyp 3 (żywy, atenuowany) 4,5 – 6,0 log10 CCID50/dawkę + Chimeryczny wirus żółtej gorączkii gorączki denga, serotyp 4 (żywy, atenuowany) 4,5 – 6,0 log10 CCID50/dawkę",
"common_name": "Czterowalentna szczepionka przeciw gorączce denga (żywa, atenuowana)",
"pl_product_id": "100416157",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about dengue-virus-impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.